Big Ten CRC News & Events
|
Spotlight on Big Ten CRC NSCLC, gastroesophageal studies
The Big Ten CRC recently featured non-small cell lung cancer studies led by Indiana University's
Greg Durm, MD (left), and
Nasser Hanna, MD (right), and a new gastroesophageal study led by the University of Wisconsin's
Nataliya Uboha, MD, PhD. Read more about these studies at the following links:
- BTCRC-LUN16-081: Phase II Study of Consolidation Immunotherapy with Nivolumab and Ipilimumab or Nivolumab alone following Concurrent Chemoradiotherapy for Unresectable Stage IIIA/IIIB Non-small Cell Lung Cancer (NSCLC)
- BTCRC-LUN17-139: A Phase II Study of Carboplatin Plus Pemetrexed Plus Atezolizumab Plus Bevacizumab in Chemotherapy and Immunotherapy-naïve Patients With Stage IV Non-squamous Non-small Cell Lung Cancer
- BTCRC-GI18-149: Phase II Study of the Combination of Abemaciclib and Pembrolizumab in Locally Advanced Unresectable or Metastatic Gastroesophageal Adenocarcinoma
|
Big Ten CRC Summit 2019
Saturday, September 21
8:00 AM - 3:15 PM
Chicago, Illinois
Registration Deadline: September 12
Join members from Big Ten Cancer Research Consortium institutions for discussions on:
- The Big Ten CRC Past, Present, and Future
- Open Trials
- Industry Updates
- Population-Based Research in the Big Ten CRC
|
Big Ten CRC appoints 11 investigators as CTWG co-chairs
The Big Ten Cancer Research Consortium recently appointed 11 investigators to serve as Big Ten CRC Clinical Trial Working Group (CTWG) co-chairs in their respective specialties. T
heir leadership supports the valuable collaboration and mentorship that takes place within working groups in support of Big Ten CRC studies.
The new co-chairs include:
(top row, l-r) Brian L. Parkin, MD, University of Michigan; Mihae Song, MD, Rutgers University; David J. VanderWeele, MD, PhD, Northwestern University
(2nd row) Dustin A. Deming, MD, University of Wisconsin; Irum Khan, MD, University of Illinois at Chicago; Pritesh R. Patel, MD, University of Illinois at Chicago
(3rd row) Nataliya V. Uboha, MD, PhD, University of Wisconsin; Vijaya R. Bhatt, MD, University of Nebraska
(bottom row) Andrew M. Evens, DO, MSc, Rutgers University; Kent Hoskins, MD, University of Illinois at Chicago; and Jeanne M. Schilder, MD, Indiana University.
|
Nasser Hanna joins Big Ten CRC Steering Committee
Nasser Hanna, MD, a thoracic oncology specialist at the Indiana University Melvin and Bren Simon Cancer Center, has been appointed to the Big Ten Cancer Research Consortium Steering Committee. As the representative for Indiana University, Dr. Hanna will work with the Steering Committee to shape research priorities for the Big Ten CRC.
Dr. Hanna previously served as chairman of Hoosier Cancer Research Network (HCRN), the administrative headquarters of the Big Ten CRC. He has been a member of the Big Ten CRC since it was founded in 2013. He is a member of the Big Ten CRC Thoracic Clinical Trial Working Group.
|
University of Wisconsin
Member Feature
Get to know University of Wisconsin researcher
Dustin Deming, MD (left), and read about the remarkable advances in lung cancer research over the past few years in comments shared by UW researcher
Ticiana Leal, MD.
Read more.
|
University of Minnesota
Member Feature
Get to know Big Ten CRC Steering Committee member and University of Minnesota researcher
Robert Kratzke, MD (right), and learn how
Veronika Bachanova, MD, PhD, and colleagues in the Big Ten CRC are working to uncover new insights into genetic alterations associated with Hodgkin lymphoma.
Read more.
|
|